Journal of Medicinal Chemistry · 2012 · 65 citations · 25 references
MedicineMedicinal ChemistryOncologyApoptosisCancer PharmacologyMolecular OncologyApoptosis PharmacologyOncology PharmacologyAdenosine Monophosphate-activated Protein Kinase PathwayAdenosine Monophosphate-activated Protein Kinase SignalingAnti-apoptotic AgentsAnticancer ActivityAntiproliferative AgentsApoptosis InductionCancer Cell ApoptosisTubulin Polymerization Inhibitors
A series of novel 1,4-diaryl-2-azetidinones were synthesized and evaluated for antiproliferative activity, cell cycle effects, and apoptosis induction. Strong cytotoxicity was observed with the best compounds (±)-trans-20, (±)-trans-21, and enantiomers (+)-trans-20 and (+)-trans-21, which exhibited IC(50) values of 3-13 nM against duodenal adenocarcinoma cells. They induced inhibition of tubulin polymerization and subsequent G2/M arrest. This effect was accompanied by activation of AMP-activated protein kinase (AMPK), activation of caspase-3, and induction of apoptosis. Additionally, the most potent compounds displayed antiproliferative activity against different colon cancer cell lines, opening the route to a new class of potential therapeutic agents against colon cancer.
25
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Dana M. Gwinn, David B. Shackelford, Daniel F. Egan et al. · Molecular Cell · 2008 · 3.8K citations · Full text
AMP-Activated Protein Kinase Induces a p53-Dependent Metabolic Checkpoint
Russell G. Jones, David R. Plas, Sara Kubek et al. · Molecular Cell · 2005 · 1.6K citations · Full text
Le Wang, Keith W. Woods, Qun Li et al. · Journal of Medicinal Chemistry · 2002 · 421 citations · Full text